| 摘要 |
<p>Antitumour compsns. contg. 8-80% of 1-(3,5-dimethoxyphenoxy)-2-morpholinoethane hydrochloride The compound was originally described in the parent patent as an antispasmodic and choleretic agent. It is not active, unlike many antitumour agents, against Ehrlich's tumour but is active against melanomas.</p> |
